Vasoactive medication requirements in the first 24 hours of cardiogenic shock: association with mortality and mechanical circulatory support

Back

ESC Professional Premium Access

Vasoactive medication requirements in the first 24 hours of cardiogenic shock: association with mortality and mechanical circulatory support

Session: Prognostication and mechanical support in cardiogenic shock

Topic: Cardiac Care Unit (CCU), Intensive, and Critical Cardiovascular Care

Speaker: Doctor D. Sarma (Rochester, US)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor Dhruv Sarma

Mayo Clinic, Rochester (United States of America)

0 follower

8 more presentations in this session

Comparison of mechanical circulatory support with venoarterial extracorporeal membrane oxygenation or Impella for patients with cardiogenic shock: a propensity-matched analysis

Speaker: Doctor G. Chatzis (Marburg, DE)

Characteristics and prognostic implications of pre-shock and normotensive cardiogenic shock in the Critical Care Cardiology Trials Network Registry

Speaker: Doctor S. Patel (Boston, US)

Combined use of VA-ECMO and Impella (ECPELLA) improves short- and long-term mortality in patients with cardiogenic shock who received VA-ECMO

Speaker: Doctor T. Unoki (Kumamoto, JP)

Trends in mechanical circulatory support use and outcomes of patients with cardiogenic shock in Japan, 2010-2020: a nationwide inpatient database study

Speaker: Doctor Y. Nishimoto (Toyonaka, JP)

Validation of SAVE score and the value of serum lactate in patients admitted for cardiogenic shock treated with VA-ECMO

Speaker: Doctor A. Bello (Carnaxide, PT)

Access the full session

Prognostication and mechanical support in cardiogenic shock

Speakers: Doctor D. Sarma, Doctor G. Chatzis, Doctor S. Patel, Doctor T. Unoki, Doctor Y. Nishimoto...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources